In vitro assessment of engineered nanomaterials using a hepatocyte cell line: Cytotoxicity, pro-inflammatory cytokines and functional markers

Nanotoxicology

Volumn 7, Issue 3, 2012, Pages 301-313

  Kermanizadeh, Ali ^a   Pojana, Giulio ^b   Gaiser, Birgit K ^a   Birkedal, Renie ^c   Bilaničová, Dagmar ^b   Wallin, Håkan ^c   Jensen, Keld Alstrup ^c   Sellergren, Börje ^d   Hutchison, Gary R ^e   Marcomini, Antonio ^b   Stone, Vicki ^a  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

^b CA' FOSCARI UNIVERSITY OF VENICE   (Italy)

^c NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^d TU DORTMUND UNIVERSITY   (Germany)

^e EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

Author keywords

Albumin; IL 8; Inflammation; Liver; Urea

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MULTI WALLED NANOTUBE; NANOMATERIAL; SILVER NANOPARTICLE; TITANIUM DIOXIDE; TUMOR NECROSIS FACTOR ALPHA; UREA; ZINC OXIDE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOPATHOGENIC EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; LC 50; LIVER CELL; LIVER FUNCTION TEST; MATERIAL COATING; NANOENGINEERING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SOLUBILITY;

EID: 84876037765     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2011.653416     Document Type: Article

References (57)

1. Al-Nasiry S, Geusens N, Hanssens M, Luyten C, Pijnenborg R. 2007. The use of Alamarblue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod 22: 1304-1309.
2. Brunauer PH, Emmet H, Teller E. 1938. Adsorption of gases in multi- molecular layers. J Am Chem Soc 60:309-315.
3. Buzea C, Pacheco II, Robbie K. 2007. Nanomaterials and nanoparticles: sources and toxicity. Biointerpahses 2:18-67.
4. Chappell MA, Miller LF, George AJ, Pettway BA, Prince CL, Porter BE, et al. 2011. Simultaneous dispersion-dissolution behaviour of concentrated silver nanoparticle suspensions in the presence of model organic solutes. Chemosphere 84:1108-1116.
5. Chen C, Zhang P, Hou X, Chai Z. 1999. Sub-cellular distribution of selenium and Se-containing proteins in human liver. Biochem Biophys Acta 1427:205-215.
6. Chen X, Schluesener HJ. 2008. Nanosilver: a nanoproduct in medical application. Toxicol Lett 176:1-12.
7. De Nicola M, Nuccitelli S, Gattia DM, Traversa E, Magrini A, Bergamaschi A, et al. 2009. Effects of carbon nanotubes on human monocytes. Natural Compounds and their Role in Apoptotic Cell Signalling Pathways. 1171:600-605.
8. Delpino MV, Barrionuevo P, Scian R, Fossati CA, Balsi PC. 2010. Brucella-infected heaptocytes mediate potentially tissue-damaging immune responses. J Hepatol 53:145-154.
9. Deng X, Luan Q, Chen W, Wang Y, Wy M, Zhang H, et al. 2009. Nanosized zinc oxide particles induce neural stem cell apoptosis. Nanotechnology 20:1-7.
10. Dong BW, Liang P, Yu XL, Zeng XQ, Wang PJ, Su L, et al. 1998. Sonographically guided microwave coagulation treatment of liver cancer: an experimental and clinical study. Am J Roentgenol 171:449-454.
11. Ellinger-Ziegelbauer H, Pauluhn J. 2009. Pulmonary toxicity of multiwalled carbon nanotubes (Baytubes(R)) relative to alpha-quartz following a single 6 hour inhalation exposure of rats and a 3 months post-exposure period. Toxicology 226:16-29.
12. Fabrega J, Luoma SN, Tyler CR, Galloway TS, Lead R. 2011. Silver nanoparticles: behaviour and effects in the aquatic environment. Environ Int 37:517-531.
13. Ferrari M. 2005. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 9:343-346.
14. Foldbjerg R, Dang DA, Autrup H. 2011. Cytotoxicity and genotoxicity of silver nanoparticles in human lung cancer line, A549. Arch Toxicol 85:743-750.
15. Gaiser BK, Biswas A, Rosenkranz P, Jepson MA, Lead JR, Stone V, et al. 2011. Effects of silver and cerum oxide micro and nano sized particles on Daphnia magna. J Environ Monit 13:1227-1235.
16. Gaiser BK, Fernandes TF, Jepson M, Lead JR, Tyler CR, Stone V. 2009. Assessing exposure, uptake and toxicity of silver and cerium dioxide nanoparticles from contaminated environments. Environ Health 8 (Suppl 1).
17. Geiser M, Kreyling WG. 2010. Deposition and biokenetics of inhaled nanoparticles. Part Fibre Toxicol 7:2-19.
18. Gekle M. 2005. Renal tubule albumin transport. Annu Rev Physiol 67:573-594.
19. Gojovo A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI. 2007. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ Health Perspect 115:403-409.
20. Hirano S, Kanno S, Furuyama A. 2008. Multi-walled carbon nanotubes injure the plasma membrane of macrophages. Toxicol Appl Pharmacol 232:244-251.
21. Hoet PHM, Hohlfeld IB, Salata O. 2004. Nanoparticles - known and unknown health risks. J Nanobiotechnology 2:12-27.
22. Huang Z, Zheng X, Yan D, Yin G, Liao X, Kang Y, et al. 2008. Toxicological effect of ZnO nanoparticles based on bacteria. Langmuir 24:4140-4144.
23. Jacobsen NR, Pojano G, Wallin H, Jensen KA. 2010. Nanomaterial dispersion protocol for toxicological studies in ENPRA. Internal ENPRA Project Report. Natl Res Centre Working Environ 6: Internal ENPRA report P1-10.
24. Jensen KA, Bilanic-ová D, Birkedal R, Pojana G, Marcomini A, Wallin H, et al.Optimization and evaluation of a generic nanoparticle dispersion protocol for in vitro and in vivo toxicity testing using serum-water. Manuscript in preparation.
25. Ji Z, Zhang D, Li L, Shen X, Deng X, Dong L, et al. 2009. The hepatotoxicity of multi-walled carbon nanotubes in mice. Nanotechnology 20:445101.
26. Jin CY, Zhu BS, Wang XF, Lu QH. 2008. Cytotoxicity of Titanium dioxide nanoparticles in mouse fibroblast cells. Chem Res Toxicol 21:1871-1877.
27. Kang SJ, Kim BM, Lee YJ, Chung HW. 2008. Titanium dioxide nanoparticles trigger p53-mediated damage response in peripheral blood lymphocytes. Environ Mol Mutagen 49:399-405.
28. Kawata K, Osawa M, Okabe S. 2009. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 43:6046-6051.
29. Kim J, Kim S, Lee S. 2011. Differentiation of the toxicities of silver nanoparticles and silver ions to the Japanese medaka (Oryzias latipes) and the cladoceran Daphnia magna. Nanotoxicology 5:208-214.
30. Kishore AS, Surekha P, Murthy PB. 2009. Assessment of the dermal and ocular irritation potential of multi-walled carbon nanotubes by using in vitro and in vivo methods. Toxicol Lett 191:268-274.
31. Kmiec Z. 2001. Co-operation of liver cells in health and disease. Adv Anat Embryol Cell Biol 161, 1-151.
32. Koeneman BA, Zhang Y, Westerhoff P, Chen Y, Crittenden JC, Capco DG. 2010. Toxicity and cellular responses of intestinal cells exposed to titanium dioxide. Cell Biol Toxicol 26:225-238.
33. Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, et al. 2011. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8:18-32.
34. Maynard AD, Aitkin RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, et al. 2006. Safe handling of nanotechnology. Nature 444:267-269.
35. Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, et al. 2007. The pro-inflammatory effects of low toxicity low solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med 64:609-615.
36. Montes-Burgos I, Walcyzk D, Hole P, Smith J, Lynch I, Dawaon K. 2010. Characterisation of nanoparticle size and state prior to nanotoxicological studies. J Nanopart Res 12:47-53.
37. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 42:1-35.
38. Oberdorster G, Oberdorster E, Oberdorster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839.
39. Park EJ, Yi J, Kim Y, Choi K, Park K. 2010. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro 24:872-878.
40. Puthothu B, Krueger M, Heinze J, Forster J, Heinzmann A. 2006. Impact of IL8 and IL8-receptor alpha polymorphisms on the genetics of bronchial asthma and severe RSV infections. Clin Mol Allergy 4:2-8.
41. Rhodes B, Furnrohr BG, Vyse TJ. 2011. C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol 7:282-289.
42. Roselli M, Finamore A, Garaguso I, Britti MS, Mengheri E. 2003. Zinc oxide protects cultured enterocytes from the damage induced by Escherichia coli. J Nutr 133:4077-4082.
43. Roursgaard M, Jensen KA, Poulsen SS, Jensen NEV, Poulsen LK, Hammer M, et al. 2011. Acute and subchronic airway inflammation after intratracheal instillation of quartz and titanium dioxide agglomerates in mice. ScientificWorld Journal 11:801-825.
44. Saad B, Frei K, Scholl FA, Fontana A, Maier P. 1995. Hepatocytederived interleukin-6 and tumour-necrosis factor alpha mediate the lipopolysaccharide- induced acute-phase response and nitric oxide release by cultured rat hepatocytes. Eur J Chem 229:349-355.
45. Sadauskas E, Jacobson NR, Danscher G, Soltenberg M, Larsen A, Kreyling W, et al. 2009. Bio-disruption of gold nanoparticles in mouse lung following intratracheal instillation. Chem Cent J 3:16-23.
46. Sadauskas E, Wallin H, Stoltenberg M, Vogel U, Doering P, Larsen A, et al. 2007. Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 4:10-17.
47. Sandhiya S, Dkhar SA, Surendiran A. 2009. Emerging trends of nanomedicine - an overview. Fundam Clin Pharmacol 23:263-269.
48. Semmler-Behnke M, Wolfgang KG, Lipka J, Fertsch S, Wenk A, Takeneka S, et al. 2008. Bio-distribution of 1.4 and 18 nm gold particles in rats. Small 12:2108-2111.
49. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, et al. 2005. Unusual inflammatory and fibrogenic pulmonary responses to single walled carbon nanotubes in mice. Am J Physiol 289:698-708.
50. Song WH, Zhang JY, Guo J, Zhang JH, Ding F, Li LY, et al. 2010. Role of dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles. Toxicol Lett 199:389-397.
51. Takenaka S, Karg E, Moller W, Roth C, Ziesenis A, Heinzmann U, et al. 2001. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 4:547-551.
52. Vermeire S, Van Assche G, Rutgeerts P. 2005. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol 2:580-586.
53. Wang JJ, Sanderson BJ, Wang H. 2007. Cyto- and genotoxicity of ultrafine TiO2 particles in cultured human lymphoblastoid cells. Mutat Res 628:99-106.
54. Wong SWY, Leung PTY, Djurisic AB, Leung KMY. 2010. Toxicities of nano zinc oxide of five marine organisms: influences of aggregate sizes and ion solubility. Anal Bioanal Chem 396:609-618.
55. Woodrow Wilson. http://www.nanotechproject.org/inventories/consumer/ browse/products/ Accessed 10 May 2011.
56. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, et al. 2006. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6:1794-1807.
57. Zheng XO, Wu R, Chen YG. 2011. Effects of ZnO nanoparticles on wastewater biological nitrogen and phosphorous removal. Environ Sci Technol 45:2826-2832.